Medicus Pharma Ltd. (MDCXW) Income from Continuing Operations (2024 - 2026)
Medicus Pharma's (MDCXW) quarterly Income from Continuing Operations came in at 7906092.0 in Q4 2025, down 118.37% YoY from 43036109.78 in Q4 2024, and down 2976.49% on a QoQ basis from 256984.0 in Q3 2025.
Medicus Pharma Ltd. (MDCXW) Income from Continuing Operations (2024 - 2026) Analysis & Trends
Medicus Pharma (MDCXW) has 2 years of Income from Continuing Operations data on file, last reported at 7906092.0 in Q4 2025.
- Quarterly Income from Continuing Operations fell 118.37% year-over-year to 7906092.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 19902734.0 (down 76.9% YoY) and the FY2025 annual result came in at 48566309.0, down 173.79% from the prior year.
- Income from Continuing Operations retreated to 7906092.0 in Q4 2025, from 256984.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 256984.0 in Q3 2025 to a low of 7906092.0 in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.68 Mn |
| Dec 31, 2025 | -7.91 Mn |
| Sep 30, 2025 | -256,984.00 |
| Jun 30, 2025 | -6.31 Mn |
| Mar 31, 2025 | -5.43 Mn |
| Dec 31, 2024 | -3.62 Mn |
| Sep 30, 2024 | -2.37 Mn |
| Jun 30, 2024 | -3.55 Mn |
| Mar 31, 2024 | -1.71 Mn |